These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29297118)

  • 1. Novel conjugates of tacrine with 1,2,4,-thiadiazole as highly effective cholinesterase inhibitors, blockers of NMDA receptors, and antioxidants.
    Makhaeva GF; Grigoriev VV; Proshin AN; Kovaleva NV; Rudakova EV; Boltneva NP; Serkov IV; Bachurin SO
    Dokl Biochem Biophys; 2017 Nov; 477(1):405-409. PubMed ID: 29297118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
    Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
    Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors.
    Gorecki L; Misiachna A; Damborsky J; Dolezal R; Korabecny J; Cejkova L; Hakenova K; Chvojkova M; Karasova JZ; Prchal L; Novak M; Kolcheva M; Kortus S; Vales K; Horak M; Soukup O
    Eur J Med Chem; 2021 Jul; 219():113434. PubMed ID: 33892271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
    Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological evaluation and molecular docking of novel 1,3,4-thiadiazole-resorcinol conjugates as multifunctional cholinesterases inhibitors.
    Skrzypek A; Matysiak J; Karpińska M; Czarnecka K; Kręcisz P; Stary D; Kukułowicz J; Paw B; Bajda M; Szymański P; Niewiadomy A
    Bioorg Chem; 2021 Feb; 107():104617. PubMed ID: 33444983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid molecules from xanomeline and tacrine: enhanced tacrine actions on cholinesterases and muscarinic M1 receptors.
    Fang L; Jumpertz S; Zhang Y; Appenroth D; Fleck C; Mohr K; Tränkle C; Decker M
    J Med Chem; 2010 Mar; 53(5):2094-103. PubMed ID: 20158205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors.
    Svobodova B; Mezeiova E; Hepnarova V; Hrabinova M; Muckova L; Kobrlova T; Jun D; Soukup O; Jimeno ML; Marco-Contelles J; Korabecny J
    Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31430943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity.
    Mao F; Chen J; Zhou Q; Luo Z; Huang L; Li X
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6737-42. PubMed ID: 24220172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of tacrine-thiadiazolidinone hybrids as dual acetylcholinesterase inhibitors.
    Dorronsoro I; Alonso D; Castro A; del Monte M; García-Palomero E; Martínez A
    Arch Pharm (Weinheim); 2005 Jan; 338(1):18-23. PubMed ID: 15674800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors.
    Pérez-Areales FJ; Turcu AL; Barniol-Xicota M; Pont C; Pivetta D; Espargaró A; Bartolini M; De Simone A; Andrisano V; Pérez B; Sabate R; Sureda FX; Vázquez S; Muñoz-Torrero D
    Eur J Med Chem; 2019 Oct; 180():613-626. PubMed ID: 31351393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties.
    Fernández-Bachiller MI; Pérez C; Monjas L; Rademann J; Rodríguez-Franco MI
    J Med Chem; 2012 Feb; 55(3):1303-17. PubMed ID: 22243648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids.
    Benchekroun M; Bartolini M; Egea J; Romero A; Soriano E; Pudlo M; Luzet V; Andrisano V; Jimeno ML; López MG; Wehle S; Gharbi T; Refouvelet B; de Andrés L; Herrera-Arozamena C; Monti B; Bolognesi ML; Rodríguez-Franco MI; Decker M; Marco-Contelles J; Ismaili L
    ChemMedChem; 2015 Mar; 10(3):523-39. PubMed ID: 25537267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
    Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
    Xie SS; Wang XB; Li JY; Yang L; Kong LY
    Eur J Med Chem; 2013 Jun; 64():540-53. PubMed ID: 23685572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly selective inhibition of butyrylcholinesterase by a novel melatonin-tacrine heterodimers.
    Zawadzka A; Lozińska I; Molęda Z; Panasiewicz M; Czarnocki Z
    J Pineal Res; 2013 May; 54(4):435-41. PubMed ID: 24325732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microwave assisted synthesis of novel hybrid tacrine-sulfonamide derivatives and investigation of their antioxidant and anticholinesterase activities.
    Ulus R; Zengin Kurt B; Gazioğlu I; Kaya M
    Bioorg Chem; 2017 Feb; 70():245-255. PubMed ID: 28153340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
    Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines.
    Romero A; Marco-Contelles J
    Curr Top Med Chem; 2017; 17(31):3328-3335. PubMed ID: 29332586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
    Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J
    J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents.
    Roldán-Peña JM; Alejandre-Ramos D; López Ó; Maya I; Lagunes I; Padrón JM; Peña-Altamira LE; Bartolini M; Monti B; Bolognesi ML; Fernández-Bolaños JG
    Eur J Med Chem; 2017 Sep; 138():761-773. PubMed ID: 28728108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.